How eXoZymes is Scaling as a Public Company
Send us Fan Mail
Guest Damien Perriman, CCO of eXoZymes, joins host Megan Thomas to talk about eXoZymes origins as a platform biotechnology company to a product-led business. Damien pulls back the curtain on the science behind their metabolic health nutraceutical, the realities of navigating an IPO, and the go-to-market strategy powering their next phase of growth.
Support the show
Follow FoodTech Stories on Apple Podcasts or Spotify. FoodTech Stories is edited by TJG Media.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.